⌕
ANI Pharmaceuticals · ANIP · Nasdaq
Tenet 69 · Solid
Compare
$70.89−0.77%At closeTenet 69 · Solid
$70.89−0.55 (−0.77%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

ANI Pharmaceuticals (ANIP) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 308 filers, Jun 30, 2026
# 13F FUNDS
308
13F VALUE
$1.9B
23.2M shares
Withheld: the 13F filers report more shares than the company has outstanding, which happens when shared or lent shares are counted twice. The filer count, shares and value are as filed.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Oct 29, 2026CAREY STEPHEN P.SVP & CFODisposed · Open-market sale2,850$72.87↗
Oct 15, 2026Lalwani NikhilPRESIDENT & CEODisposed · Open-market sale5,400$71.89↗
Oct 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Disposed · Open-market sale500$73.59↗
Sep 29, 2026CAREY STEPHEN P.SVP & CFODisposed · Open-market sale2,850$73.00↗
Sep 15, 2026Lalwani NikhilPRESIDENT & CEODisposed · Open-market sale5,400$71.00↗
Sep 14, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Disposed · Open-market sale500$70.79↗
Sep 11, 2026Thoma JeannedirectorDisposed · Open-market sale1,000$71.53↗
Aug 31, 2026CAREY STEPHEN P.SVP & CFODisposed · Open-market sale2,850$72.80↗
Aug 25, 2026Lalwani NikhilPRESIDENT & CEODisposed · Open-market sale5,400$74.30↗
Aug 19, 2026Gosebruch Henry OdirectorAcquired · Grant / award6,662—↗
Aug 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Disposed · Open-market sale500$75.48↗
Aug 10, 2026Gutwerg OriSVP, GENERICSDisposed · Open-market sale3,162$77.00↗
Jul 29, 2026CAREY STEPHEN P.SVP & CFODisposed · Open-market sale2,850$81.36↗
Jul 18, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Disposed · Tax withholding2,466$79.20↗
Jul 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Disposed · Open-market sale500$81.84↗
Jul 2, 2026CAREY STEPHEN P.SVP & CFOAcquired · Option exercise3,313$49.51↗
Jul 2, 2026CAREY STEPHEN P.SVP & CFODisposed · Open-market sale3,313$86.00↗
Jul 2, 2026CAREY STEPHEN P.SVP & CFODisposed · Option exercise3,313Stock Option (right to buy)$49.51↗
Jun 29, 2026CAREY STEPHEN P.SVP & CFODisposed · Open-market sale2,850$84.12↗
Jun 12, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Disposed · Open-market sale500$82.03↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold ANI Pharmaceuticals?

ANI Pharmaceuticals was held by 308 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.